In a mouse model of liver fibrosis, hepatic stellate cells activation is accompanied by a switch in arginine catabolism resulting from downregulation of NOS and upregulation of arginase-1; therefore, inhibition of arginase-1 has been proposed as an anti-fibrotic target for the treatment of liver fibrosis [45]. The gene discussed is ARG1; the disease is Hepatic fibrosis.